http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 01 Sep 2026 08:00:24 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Management+Changes/Profound+Medical+names+Richard+Fabian+as+president/27009079.html <p>Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) has appointed Richard Fabian as president, effective immediately, according to a press release from the Toronto-based medical device company.</p> <p>Fabian succeeds Mathieu Burtnyk, PhD, who moves to a newly created role of Chief Technology Officer. Burtnyk is credited as the inventor of the patented closed-loop temperature feedback control algorithm used in the company's TULSA-PRO device and has led clinical studies for the technology, including the ongoing CAPTAIN randomized controlled trial.</p> <p>Fabian brings more than 29 years of experience in the healthcare industry, with a background in medical imaging and medical devices. He most recently served http://www.streetinsider.com/Management+Changes/Profound+Medical+names+Richard+Fabian+as+president/27009079.html Tue, 01 Sep 2026 08:00:24 -0400 PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Further+Strengthens+Executive+Leadership+Team+with+Appointment+of+Richard+Fabian+as+President/27008998.html <p align="justify">TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=p8pjljEcEoytn1HHYxoUysJW9htl9H2NnszQyMRhjPucUpFWLhDF_nrkuwMDCvjixzO5VbpDWVTpbguh8QkNaA4lWEWchLP4wC4H1xY02-8=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced the appointment of Richard Fabian as its new President, effective immediately. Mr. Fabian succeeds Mathieu Burtnyk, PhD, who has shifted to the newly created position of Chief Technology Officer.</p> <p align="justify">Mr. Fabian has an accomplished history of sales, marketing, operations, general and executive management success within the global healthcare industry, specifically in the medical imaging and medical device spaces. In a http://www.streetinsider.com/Press+Releases/Profound+Medical+Further+Strengthens+Executive+Leadership+Team+with+Appointment+of+Richard+Fabian+as+President/27008998.html Tue, 01 Sep 2026 08:00:00 -0400 PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Further+Strengthens+Executive+Leadership+Team+with+Appointment+of+Richard+Fabian+as+President/27008998.html <p align="justify">TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=p8pjljEcEoytn1HHYxoUysJW9htl9H2NnszQyMRhjPucUpFWLhDF_nrkuwMDCvjixzO5VbpDWVTpbguh8QkNaA4lWEWchLP4wC4H1xY02-8=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced the appointment of Richard Fabian as its new President, effective immediately. Mr. Fabian succeeds Mathieu Burtnyk, PhD, who has shifted to the newly created position of Chief Technology Officer.</p> <p align="justify">Mr. Fabian has an accomplished history of sales, marketing, operations, general and executive management success within the global healthcare industry, specifically in the medical imaging and medical device spaces. In a http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Further+Strengthens+Executive+Leadership+Team+with+Appointment+of+Richard+Fabian+as+President/27008998.html Tue, 01 Sep 2026 08:00:00 -0400 PROF http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+17/26935417.html si-local-file:///var/storage/secattach/20260817/26935417.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+17/26935417.html Mon, 17 Aug 2026 08:35:00 -0400 O.19076731 PROF http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+17/26935417.html si-local-file:///var/storage/secattach/20260817/26935417.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+17/26935417.html Mon, 17 Aug 2026 08:35:00 -0400 O.19076731 PROF http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+14/26934826.html si-local-file:///var/storage/secattach/20260817/26934826.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+14/26934826.html Mon, 17 Aug 2026 07:30:00 -0400 O.19076731 PROF http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+14/26934826.html si-local-file:///var/storage/secattach/20260817/26934826.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+14/26934826.html Mon, 17 Aug 2026 07:30:00 -0400 O.19076731 PROF http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+13/26921853.html si-local-file:///var/storage/secattach/20260813/26921853.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+13/26921853.html Thu, 13 Aug 2026 16:31:00 -0400 O.19076731 PROF http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+13/26921853.html si-local-file:///var/storage/secattach/20260813/26921853.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+13/26921853.html Thu, 13 Aug 2026 16:31:00 -0400 O.19076731 PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html <p align="justify">TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=EIPK8rvdh0W6ayZ12DYDH_aM8bDLu3mxCdE7Gi6-8RSe45ChOY5CsTKRL3-0eUtm7p7zV8VZONO-X1ESMbTsAVdNpbgF5XanBh8zFFA1qUN6VOMNnZUON08KU0UkjUG_-1eLFma2Jl8vDrdZjQGT4YQOfnPDczjTQ-oPvW0q_JjZ9o7MSmysIe5vY5vgkxdUczqeS5eERqkRZnNBp_r-nG_ivJGeZdLMCYWNPNKR3tzPtugtjzSXhJgEjf1GqgaD56JIBzVZAeDTMSmxg2JXag==" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today announced the launch of <em>Let&apos;s Huddle</em>, a global patient community designed to empower men and their families with education, connection, and support throughout every stage of the prostate care journey.</p> <p align="justify">The new patient advocacy initiative, led by Leonard Wheeler, Profound’s Global Patient Ambassador, former NFL player, prostate cancer survivor, and men&apos;s health advocate, brings together patients, survivors, care partners, healthcare professionals, http://www.streetinsider.com/Press+Releases/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html Thu, 13 Aug 2026 16:15:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html <p align="justify">TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=EIPK8rvdh0W6ayZ12DYDH_aM8bDLu3mxCdE7Gi6-8RSe45ChOY5CsTKRL3-0eUtm7p7zV8VZONO-X1ESMbTsAVdNpbgF5XanBh8zFFA1qUN6VOMNnZUON08KU0UkjUG_-1eLFma2Jl8vDrdZjQGT4YQOfnPDczjTQ-oPvW0q_JjZ9o7MSmysIe5vY5vgkxdUczqeS5eERqkRZnNBp_r-nG_ivJGeZdLMCYWNPNKR3tzPtugtjzSXhJgEjf1GqgaD56JIBzVZAeDTMSmxg2JXag==" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today announced the launch of <em>Let&apos;s Huddle</em>, a global patient community designed to empower men and their families with education, connection, and support throughout every stage of the prostate care journey.</p> <p align="justify">The new patient advocacy initiative, led by Leonard Wheeler, Profound’s Global Patient Ambassador, former NFL player, prostate cancer survivor, and men&apos;s health advocate, brings together patients, survivors, care partners, healthcare professionals, http://www.streetinsider.com/Press+Releases/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html Thu, 13 Aug 2026 16:15:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html <p align="justify">TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=EIPK8rvdh0W6ayZ12DYDH_aM8bDLu3mxCdE7Gi6-8RSe45ChOY5CsTKRL3-0eUtm7p7zV8VZONO-X1ESMbTsAVdNpbgF5XanBh8zFFA1qUN6VOMNnZUON08KU0UkjUG_-1eLFma2Jl8vDrdZjQGT4YQOfnPDczjTQ-oPvW0q_JjZ9o7MSmysIe5vY5vgkxdUczqeS5eERqkRZnNBp_r-nG_ivJGeZdLMCYWNPNKR3tzPtugtjzSXhJgEjf1GqgaD56JIBzVZAeDTMSmxg2JXag==" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today announced the launch of <em>Let&apos;s Huddle</em>, a global patient community designed to empower men and their families with education, connection, and support throughout every stage of the prostate care journey.</p> <p align="justify">The new patient advocacy initiative, led by Leonard Wheeler, Profound’s Global Patient Ambassador, former NFL player, prostate cancer survivor, and men&apos;s health advocate, brings together patients, survivors, care partners, healthcare professionals, http://www.streetinsider.com/Press+Releases/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html Thu, 13 Aug 2026 16:15:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html <p align="justify">TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=EIPK8rvdh0W6ayZ12DYDH_aM8bDLu3mxCdE7Gi6-8RSe45ChOY5CsTKRL3-0eUtm7p7zV8VZONO-X1ESMbTsAVdNpbgF5XanBh8zFFA1qUN6VOMNnZUON08KU0UkjUG_-1eLFma2Jl8vDrdZjQGT4YQOfnPDczjTQ-oPvW0q_JjZ9o7MSmysIe5vY5vgkxdUczqeS5eERqkRZnNBp_r-nG_ivJGeZdLMCYWNPNKR3tzPtugtjzSXhJgEjf1GqgaD56JIBzVZAeDTMSmxg2JXag==" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today announced the launch of <em>Let&apos;s Huddle</em>, a global patient community designed to empower men and their families with education, connection, and support throughout every stage of the prostate care journey.</p> <p align="justify">The new patient advocacy initiative, led by Leonard Wheeler, Profound’s Global Patient Ambassador, former NFL player, prostate cancer survivor, and men&apos;s health advocate, brings together patients, survivors, care partners, healthcare professionals, http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html Thu, 13 Aug 2026 16:15:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html <p align="justify">TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=EIPK8rvdh0W6ayZ12DYDH_aM8bDLu3mxCdE7Gi6-8RSe45ChOY5CsTKRL3-0eUtm7p7zV8VZONO-X1ESMbTsAVdNpbgF5XanBh8zFFA1qUN6VOMNnZUON08KU0UkjUG_-1eLFma2Jl8vDrdZjQGT4YQOfnPDczjTQ-oPvW0q_JjZ9o7MSmysIe5vY5vgkxdUczqeS5eERqkRZnNBp_r-nG_ivJGeZdLMCYWNPNKR3tzPtugtjzSXhJgEjf1GqgaD56JIBzVZAeDTMSmxg2JXag==" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today announced the launch of <em>Let&apos;s Huddle</em>, a global patient community designed to empower men and their families with education, connection, and support throughout every stage of the prostate care journey.</p> <p align="justify">The new patient advocacy initiative, led by Leonard Wheeler, Profound’s Global Patient Ambassador, former NFL player, prostate cancer survivor, and men&apos;s health advocate, brings together patients, survivors, care partners, healthcare professionals, http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html Thu, 13 Aug 2026 16:15:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html <p align="justify">TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=EIPK8rvdh0W6ayZ12DYDH_aM8bDLu3mxCdE7Gi6-8RSe45ChOY5CsTKRL3-0eUtm7p7zV8VZONO-X1ESMbTsAVdNpbgF5XanBh8zFFA1qUN6VOMNnZUON08KU0UkjUG_-1eLFma2Jl8vDrdZjQGT4YQOfnPDczjTQ-oPvW0q_JjZ9o7MSmysIe5vY5vgkxdUczqeS5eERqkRZnNBp_r-nG_ivJGeZdLMCYWNPNKR3tzPtugtjzSXhJgEjf1GqgaD56JIBzVZAeDTMSmxg2JXag==" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today announced the launch of <em>Let&apos;s Huddle</em>, a global patient community designed to empower men and their families with education, connection, and support throughout every stage of the prostate care journey.</p> <p align="justify">The new patient advocacy initiative, led by Leonard Wheeler, Profound’s Global Patient Ambassador, former NFL player, prostate cancer survivor, and men&apos;s health advocate, brings together patients, survivors, care partners, healthcare professionals, http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Launches+%E2%80%98Let%26apos%3Bs+Huddle%E2%80%99%2C+a+Global+Community+Supporting+Men+Throughout+Their+Prostate+Care+Journey/26921262.html Thu, 13 Aug 2026 16:15:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Earnings/Profound+Medical+Corp.+%28PROF%29+Misses+Q2+EPS+by+2c/26885589.html <p>Profound Medical Corp. (NASDAQ: PROF) reported Q2 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $5.08 million.</p><p>For earnings history and earnings-related data on Profound Medical Corp. (PROF) <a href="http://www.streetinsider.com/ec_earnings.php?q=PROF">click here</a>.</p> http://www.streetinsider.com/Earnings/Profound+Medical+Corp.+%28PROF%29+Misses+Q2+EPS+by+2c/26885589.html Thu, 06 Aug 2026 17:17:54 -0400 PROF http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Profound+Medical+Corp.++++For%3A+Jun+30/26884814.html si-local-file:///var/storage/secattach/20260806/26884814.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Profound+Medical+Corp.++++For%3A+Jun+30/26884814.html Thu, 06 Aug 2026 16:33:00 -0400 O.19076731 PROF http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Profound+Medical+Corp.++++For%3A+Jun+30/26884814.html si-local-file:///var/storage/secattach/20260806/26884814.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Profound+Medical+Corp.++++For%3A+Jun+30/26884814.html Thu, 06 Aug 2026 16:33:00 -0400 O.19076731 PROF http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+06/26884456.html si-local-file:///var/storage/secattach/20260806/26884456.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+06/26884456.html Thu, 06 Aug 2026 16:20:00 -0400 O.19076731 PROF http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+06/26884456.html si-local-file:///var/storage/secattach/20260806/26884456.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Profound+Medical+Corp.++++For%3A+Aug+06/26884456.html Thu, 06 Aug 2026 16:20:00 -0400 O.19076731 PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html <p align="center"><em>– Operating expenses decline 16%, helping drive a 39% improvement in net loss –</em></p> <p align="center"><em>– Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing –</em></p> <p align="center"><em>– Strong clinical, commercial and reimbursement momentum continues –</em></p> <p align="center"><em>– Company reiterates full-year 2026 revenue guidance –</em></p> <p align="center"><em>– Announces first employer owned health plans to list the TULSA Procedure™ as a covered service –</em></p> <p align="justify">TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4ZhqjetOr21cEt90lpJlWI3-vWXRYptkyk5s0XoHL_bScvGLgd9Fv_OuTxlaHP9Y9AY8xR3vCjE2BrJQlf1cijw_Ye05iI0vA29Fh5I5jFg=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage http://www.streetinsider.com/Press+Releases/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html Thu, 06 Aug 2026 16:12:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html <p align="center"><em>– Operating expenses decline 16%, helping drive a 39% improvement in net loss –</em></p> <p align="center"><em>– Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing –</em></p> <p align="center"><em>– Strong clinical, commercial and reimbursement momentum continues –</em></p> <p align="center"><em>– Company reiterates full-year 2026 revenue guidance –</em></p> <p align="center"><em>– Announces first employer owned health plans to list the TULSA Procedure™ as a covered service –</em></p> <p align="justify">TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4ZhqjetOr21cEt90lpJlWI3-vWXRYptkyk5s0XoHL_bScvGLgd9Fv_OuTxlaHP9Y9AY8xR3vCjE2BrJQlf1cijw_Ye05iI0vA29Fh5I5jFg=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage http://www.streetinsider.com/Press+Releases/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html Thu, 06 Aug 2026 16:12:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html <p align="center"><em>– Operating expenses decline 16%, helping drive a 39% improvement in net loss –</em></p> <p align="center"><em>– Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing –</em></p> <p align="center"><em>– Strong clinical, commercial and reimbursement momentum continues –</em></p> <p align="center"><em>– Company reiterates full-year 2026 revenue guidance –</em></p> <p align="center"><em>– Announces first employer owned health plans to list the TULSA Procedure™ as a covered service –</em></p> <p align="justify">TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4ZhqjetOr21cEt90lpJlWI3-vWXRYptkyk5s0XoHL_bScvGLgd9Fv_OuTxlaHP9Y9AY8xR3vCjE2BrJQlf1cijw_Ye05iI0vA29Fh5I5jFg=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage http://www.streetinsider.com/Press+Releases/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html Thu, 06 Aug 2026 16:12:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html <p align="center"><em>– Operating expenses decline 16%, helping drive a 39% improvement in net loss –</em></p> <p align="center"><em>– Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing –</em></p> <p align="center"><em>– Strong clinical, commercial and reimbursement momentum continues –</em></p> <p align="center"><em>– Company reiterates full-year 2026 revenue guidance –</em></p> <p align="center"><em>– Announces first employer owned health plans to list the TULSA Procedure™ as a covered service –</em></p> <p align="justify">TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4ZhqjetOr21cEt90lpJlWI3-vWXRYptkyk5s0XoHL_bScvGLgd9Fv_OuTxlaHP9Y9AY8xR3vCjE2BrJQlf1cijw_Ye05iI0vA29Fh5I5jFg=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html Thu, 06 Aug 2026 16:12:00 -0400 O.19076731 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html <p align="center"><em>– Operating expenses decline 16%, helping drive a 39% improvement in net loss –</em></p> <p align="center"><em>– Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing –</em></p> <p align="center"><em>– Strong clinical, commercial and reimbursement momentum continues –</em></p> <p align="center"><em>– Company reiterates full-year 2026 revenue guidance –</em></p> <p align="center"><em>– Announces first employer owned health plans to list the TULSA Procedure™ as a covered service –</em></p> <p align="justify">TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4ZhqjetOr21cEt90lpJlWI3-vWXRYptkyk5s0XoHL_bScvGLgd9Fv_OuTxlaHP9Y9AY8xR3vCjE2BrJQlf1cijw_Ye05iI0vA29Fh5I5jFg=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage http://www.streetinsider.com/Globe+Newswire/Profound+Medical+Reports+Second+Quarter+2026+Financial+Results/26883864.html Thu, 06 Aug 2026 16:12:00 -0400 O.19076731 PRN PROF